These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28546555)

  • 1. Peptide-specific engagement of the activating NK cell receptor KIR2DS1.
    Chapel A; Garcia-Beltran WF; Hölzemer A; Ziegler M; Lunemann S; Martrus G; Altfeld M
    Sci Rep; 2017 May; 7(1):2414. PubMed ID: 28546555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance.
    Le Luduec JB; Boudreau JE; Freiberg JC; Hsu KC
    Front Immunol; 2019; 10():734. PubMed ID: 31024561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
    Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
    Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans.
    Blokhuis JH; Hilton HG; Guethlein LA; Norman PJ; Nemat-Gorgani N; Nakimuli A; Chazara O; Moffett A; Parham P
    Immun Inflamm Dis; 2017 Dec; 5(4):461-468. PubMed ID: 28685972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
    Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
    J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
    Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
    Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.
    Stewart CA; Laugier-Anfossi F; Vély F; Saulquin X; Riedmuller J; Tisserant A; Gauthier L; Romagné F; Ferracci G; Arosa FA; Moretta A; Sun PD; Ugolini S; Vivier E
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13224-9. PubMed ID: 16141329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I.
    Moesta AK; Graef T; Abi-Rached L; Older Aguilar AM; Guethlein LA; Parham P
    J Immunol; 2010 Oct; 185(7):4233-7. PubMed ID: 20802150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.
    Fauriat C; Ivarsson MA; Ljunggren HG; Malmberg KJ; Michaëlsson J
    Blood; 2010 Feb; 115(6):1166-74. PubMed ID: 19903900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
    Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
    Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.
    Xiong S; Sharkey AM; Kennedy PR; Gardner L; Farrell LE; Chazara O; Bauer J; Hiby SE; Colucci F; Moffett A
    J Clin Invest; 2013 Oct; 123(10):4264-72. PubMed ID: 24091323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.
    David G; Morvan M; Gagne K; Kerdudou N; Willem C; Devys A; Bonneville M; Folléa G; Bignon JD; Retière C
    Immunology; 2009 Oct; 128(2):172-84. PubMed ID: 19740374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
    Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
    Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate receptors with high specificity for HLA class I-peptide complexes.
    Sim MJW; Brennan P; Wahl KL; Lu J; Rajagopalan S; Sun PD; Long EO
    Sci Immunol; 2023 Sep; 8(87):eadh1781. PubMed ID: 37683038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions.
    Morvan M; David G; Sébille V; Perrin A; Gagne K; Willem C; Kerdudou N; Denis L; Clémenceau B; Folléa G; Bignon JD; Retière C
    Eur J Immunol; 2008 Dec; 38(12):3474-86. PubMed ID: 19016529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients.
    Johansson SE; Hejdeman B; Hinkula J; Johansson MH; Romagné F; Wahren B; Wagtmann NR; Kärre K; Berg L
    Clin Immunol; 2010 Feb; 134(2):158-68. PubMed ID: 19880352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
    Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
    J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.